title: Location and duration of treatment of cystic fibrosis respiratory exacerbations.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Schechter
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Wagener
authors.forename: Michael W
authors.initials: MW
authors.lastname: Konstan
authors.forename: Wayne
authors.initials: W
authors.lastname: Morgan
mesh_terms: D000293:Adolescent; D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005260:Female; D005541:Forced Expiratory Volume; D006760:Hospitalization; D006801:Humans; D007262:Infusions, Intravenous; D007902:Length of Stay; D010044:Outpatient Clinics, Hospital; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents